Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valette

Showing results (91-100 of 92) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 92 results.
Pharmaceutical Research|April 2, 1998
Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayersP Annaert, G Gosselin, A Pompon, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
Pageof 10

Showing results (91-100 of 92) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 92 results.
Pharmaceutical Research|April 2, 1998
Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayersP Annaert, G Gosselin, A Pompon, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
Pageof 10